Halozyme Therapeutics Inc (NASDAQ:HALO)

19.08
Delayed Data
As of Apr 26
 +0.42 / +2.25%
Today’s Change
11.41
Today|||52-Week Range
21.48
-5.82%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Torley Helen I
President & Chief Executive Officer
Sale2/03/201824,111$18.37$442.9K+7.43%
Torley Helen I
President & Chief Executive Officer
Sale2/22/201819,511$19.28$376.2K-1.04%
Torley Helen I
President & Chief Executive Officer
Sale2/06/201815,493$18.25$282.7K+4.55%
Torley Helen I
President & Chief Executive Officer
Sale1/06/201811,649$19.46$226.7K+1.92%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale2/03/20188,265$18.37$151.8K+7.43%
Third Security Llc
Director
Buy5/11/201710,000$10.37$103.7K+37.27%
Matsui Connie L
Director
Buy5/08/201710,000$10.37$103.7K+37.76%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale2/03/20185,605$18.37$103.0K+7.43%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale2/22/20183,939$19.28$75.9K-1.04%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale2/22/20183,939$19.28$75.9K-1.04%
Page of 3